Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|January 19, 2007
Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatmentP B Miner, L D Allgood, J M Grender
Gastroenterology|June 1, 1981
The effect of ethanol on hepatic sodium plus potassium activated adenosine triphosphatase activity in the ratR L Ricci, S S Crawford, P B Miner
Alimentary Pharmacology & Therapeutics|December 21, 2004
Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitorJ D Gardner, S Sloan, M Robinson, et al.
Gastroenterology|June 1, 1995
Exacerbation of chronic ulcerative colitis with mesalamineJ B Sturgeon, P Bhatia, D Hermens, et al.
Digestive Diseases and Sciences|January 1, 1989
Gastric mucosal nodules due to cytomegalovirus infectionL D Shuster, G Cox, P Bhatia, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2003
Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitorJ D Gardner, S Sloan, P B Miner, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2004
Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjectsJ D Gardner, S Sloan, M Robinson, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2003
Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitorJ D Gardner, S Sloan, M Robinson, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2003
Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux diseaseJ D Gardner, S Sloan, P B Miner, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled studyJ F Tack, P B Miner, L Fischer, et al.
Pageof 7